A Guideline Review for Osteoporosis

Osteoporosis may be a forgotten disease – common but rarely treated. The 2023 guidelines are not here. Join host, Geoff Wall, as he reviews the new treatment recommendations and how we can optimize pharmacotherapy for all persons with osteoporosis.The GameChangerOsteoporosis is common and routine screenings should be implemented. Bisphosphonates are still the drug of choice, but treatment for persons over 65 should be made on a case-by-case basis.Show Segments00:00 - Introduction00:25 - Background on Osteoporosis04:17 - How Guidelines Are Formed08:45 - Bisphosphonate Recommendation14:14 - Denosumab Recommendation16:40 - Anabolic Drugs20:40 - SERMs22:24 - The GameChanger: Recommendations Summary27:20 - Closing Remarks HostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesPharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. FRAX Calculator Redeem your CPE hereCPE (Pharmacist) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the epidemiology and diagnosis of osteoporosis2. Apply the treatment guidelines for osteoporosis to a specific patient0.05 CEU/0.5 HrUAN: 0107-0000-23-063-H01-PInitial release date: 01/06/2023Expiration date: 01/06/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram